VitreJect Syringe— 510(k) K230372
Substantially EquivalentOcuject, LLC
FDA 510(k) clearance K230372 for VitreJect Syringe, Substantially Equivalent on 2023-09-08. Applicant: Ocuject, LLC.
Clearance details
- Applicant
- Ocuject, LLC
- Product code
- Code QLY
- Advisory panel
- General Hospital
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Newport Beach, CA, US
Data sourced from openFDA. This site is unofficial and independent of the FDA.